Zim Laboratories

81.12
-1.32
(-1.60%)
Market Cap
395.26 Cr
EPS
3.54
PE Ratio
26.19
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
131.40
52 Week low
80.96
PB Ratio
1.66
Debt to Equity
0.40
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
-7.98 %
Net Income Growth
-29.51 %
Cash Flow Change
-57.35 %
ROE
-40.82 %
ROCE
-39.99 %
EBITDA Margin (Avg.)
-13.45 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
64
64
75
79
71
72
99
95
69
68
74
72
71
88
76
75
65
78
87
107
95
101
103
106
69
87
97
119
83
94
98
Expenses
57
55
64
62
62
61
85
84
64
63
65
62
60
81
67
65
59
67
76
90
82
87
88
90
63
77
85
102
74
83
85
EBITDA
7
9
11
17
9
11
13
11
4
5
9
9
11
8
8
10
7
11
11
16
13
14
16
16
6
11
13
17
9
11
13
Operating Profit %
11 %
13 %
15 %
13 %
12 %
14 %
13 %
11 %
5 %
7 %
11 %
10 %
15 %
9 %
10 %
12 %
8 %
13 %
12 %
14 %
12 %
12 %
13 %
15 %
7 %
11 %
12 %
13 %
10 %
10 %
12 %
Depreciation
2
2
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
4
4
4
4
5
5
5
Interest
2
3
2
3
3
3
3
3
3
3
3
3
3
3
2
3
3
3
2
1
1
1
2
1
2
1
2
2
3
3
3
Profit Before Tax
3
4
7
11
4
5
8
5
-2
-2
2
3
4
1
2
3
0
4
6
11
8
8
10
10
0
5
7
11
1
3
6
Tax
1
1
1
3
0
1
2
3
-3
-1
0
0
1
0
1
1
0
1
2
4
2
3
3
3
0
1
2
3
0
1
2
Net Profit
2
3
6
8
4
3
6
2
0
-1
2
2
3
1
1
2
0
3
4
7
5
5
7
7
0
4
5
8
1
2
4
EPS in ₹
2.66
1.79
7.81
4.84
2.35
2.08
3.65
1.43
0.05
-0.37
0.94
1.41
2.02
0.73
0.80
0.95
0.12
2.00
2.51
4.33
3.17
3.35
1.35
1.48
0.05
0.85
0.98
1.66
0.18
0.49
0.82

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
265
256
259
298
329
325
325
342
342
447
Fixed Assets
87
92
89
94
106
116
107
106
109
161
Current Assets
168
154
154
173
194
182
192
212
191
228
Capital Work in Progress
6
3
4
8
13
10
11
12
27
42
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
172
161
166
196
209
200
208
224
206
244
Total Liabilities
265
256
259
298
329
325
325
342
342
447
Current Liabilities
133
122
113
141
155
143
142
146
111
159
Non Current Liabilities
38
35
28
20
22
28
22
20
30
49
Total Equity
94
99
118
137
151
154
161
176
200
239
Reserve & Surplus
86
91
110
129
135
138
145
160
152
190
Share Capital
8
8
8
8
16
16
16
16
49
49

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-7
-0
-0
1
-1
1
-0
2
3
3
Investing Activities
-9
-12
-7
-26
-21
-19
-6
-14
-36
-73
Operating Activities
6
22
32
37
35
22
32
49
38
16
Financing Activities
-4
-10
-25
-10
-15
-2
-26
-33
1
60

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.21 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.11 %
0.10 %
0.24 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.73 %
51.92 %
51.96 %
50.67 %
50.77 %
51.15 %
50.96 %
51.57 %
51.57 %
49.90 %
50.74 %
50.92 %
49.01 %
49.21 %
45.48 %
44.39 %
Others
36.01 %
14.81 %
14.77 %
16.06 %
15.97 %
15.59 %
15.78 %
15.17 %
15.16 %
16.84 %
15.99 %
15.82 %
17.72 %
17.42 %
21.15 %
21.90 %
No of Share Holders
4,600
4,887
4,610
3,646
3,561
3,569
3,643
5,595
5,879
8,982
15,305
17,342
17,100
17,483
17,716
17,450

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 28, 2025, 16:17
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 28, 2025, 16:17
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 19, 2025, 19:27
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 13, 2025, 13:48
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 12, 2025, 12:18
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 11, 2025, 17:52
Integrated Filing (Financial)
Feb 10, 2025, 21:29
Q3 & 9M FY25 - Earnings Presentation
Feb 10, 2025, 20:28
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024 Is Enclosed Herewith.
Feb 10, 2025, 19:40
Board Meeting Outcome for Outcome Of Board Meeting Held On 10.02.2025
Feb 10, 2025, 19:29
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December 2024.
Feb 03, 2025, 20:09
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 10, 2025, 18:11
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 08, 2025, 18:33
Change Of Name Of The Registrar And Share Transfer Agent ("RTA") Of The Company
Jan 02, 2025, 18:56
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 27, 2024, 16:06
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 10, 2024, 12:43
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 06, 2024, 17:03
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 06, 2024, 16:54
Reply To The Clarification Sought On Increase In Trading Volume Of The Shares Of The Company
Dec 05, 2024, 12:51
Clarification sought from Zim Laboratories Ltd
Dec 05, 2024, 11:30
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 03, 2024, 16:52
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 03, 2024, 16:50
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 02, 2024, 17:02
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 02, 2024, 16:55
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 25, 2024, 16:37
Announcement under Regulation 30 (LODR)-Credit Rating
Nov 25, 2024, 13:07
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 19, 2024, 16:49
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Nov 15, 2024, 19:59
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Nov 15, 2024, 19:58
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 15, 2024, 12:25
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 11, 2024, 18:44
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 11, 2024, 15:21
Q2 & H1 FY25 - Earnings Presentation
Nov 09, 2024, 20:16
Financial Results For The Quarter And Half Year Ended 30Th September, 2024
Nov 09, 2024, 19:36
Announcement under Regulation 30 (LODR)-Change in Management
Nov 09, 2024, 18:45
Board Meeting Outcome for Outcome Of Board Meeting Held On 09.11.2024
Nov 09, 2024, 18:36
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 05, 2024, 20:13
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations& Disclosure Requirements) Regulations, 2015
Nov 04, 2024, 21:07
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 29, 2024, 18:41
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 17, 2024, 14:15
Announcement under Regulation 30 (LODR)-Credit Rating
Oct 09, 2024, 18:03
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 08, 2024, 16:26
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 05, 2024, 18:20
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Oct 01, 2024, 11:54
Announcement under Regulation 30 (LODR)-Acquisition
Sep 30, 2024, 19:28
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 25, 2024, 12:42
Closure of Trading Window
Sep 25, 2024, 12:16
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sep 18, 2024, 15:51
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 12, 2024, 18:17
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sep 06, 2024, 12:55

Technical Indicators

RSI(14)
Neutral
31.84
ATR(14)
Less Volatile
4.91
STOCH(9,6)
Neutral
24.83
STOCH RSI(14)
Neutral
37.38
MACD(12,26)
Bearish
-0.53
ADX(14)
Weak Trend
16.70
UO(9)
Bullish
28.89
ROC(12)
Downtrend But Slowing Down
-13.27
WillR(14)
Oversold
-90.16